𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeting circulatory dysfunction in cirrhosis: Terlipressin and the hepatorenal syndrome

✍ Scribed by Adam G Testro; Peter W Angus

Book ID
108952464
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
69 KB
Volume
24
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Circulatory function and hepatorenal syn
Circulatory function and hepatorenal syndrome in cirrhosis
✍ Luis Ruiz-del-Arbol; Alberto Monescillo; Carlos Arocena; Paz Valer; Pere GinΓ¨s; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 158 KB

The pathogenic mechanism of hepatorenal syndrome is not well established. We investigated the circulatory function in cirrhosis before and after the development of hepatorenal syndrome. Systemic and hepatic hemodynamics and the activity of endogenous vasoactive systems were measured in 66 patients w

Terlipressin improves renal function in
Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome
✍ Aleksander Krag; SΓΈren MΓΈller; Jens H. Henriksen; Niels-Henrik Holstein-Rathlou; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 1 views

Patients with advanced cirrhosis and ascites are characterized by circulatory dysfunction with splanchnic vasodilatation and renal vasoconstriction, which often lead to ascites. The vasoconstrictor terlipressin improves renal function in hepatorenal syndrome (HRS). The aim of this study was to evalu

Predictors of response to therapy with t
Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome
✍ AndrΓ© Nazar; Gustavo Henrique Pereira; MΓ³nica Guevara; Marta MartΓ­n-Llahi; Marie πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 169 KB πŸ‘ 1 views

Terlipressin plus albumin is an effective treatment for type 1 hepatorenal syndrome (HRS), but approximately only half of the patients respond to this therapy. The aim of this study was to assess predictive factors of response to treatment with terlipressin and albumin in patients with type 1 HRS. T

Tubular dysfunction in the deeply jaundi
Tubular dysfunction in the deeply jaundiced patient with hepatorenal syndrome
✍ William G. Rector Jr; Gary C. Kanel; Jorge Rakela; Telfer B. Reynolds πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 608 KB

We examined &-microglobulin (BZMG) excretion, an index of tubular function, in patients with hepatorenal syndrome, in whom tubular function is generally regarded as normal. Urine BBMG was significantly higher in these patients than in control patients with normal serum creatinine concentration. Pati